[go: up one dir, main page]

AU2001233934A1 - Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis - Google Patents

Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis

Info

Publication number
AU2001233934A1
AU2001233934A1 AU2001233934A AU3393401A AU2001233934A1 AU 2001233934 A1 AU2001233934 A1 AU 2001233934A1 AU 2001233934 A AU2001233934 A AU 2001233934A AU 3393401 A AU3393401 A AU 3393401A AU 2001233934 A1 AU2001233934 A1 AU 2001233934A1
Authority
AU
Australia
Prior art keywords
ccr2
atherosclerosis
diagnostic
treatment
polymorphic variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233934A
Inventor
Pieter Hendrik Evert Groot
Nigel Kay Spurr
Ana Maria Valdes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001233934A1 publication Critical patent/AU2001233934A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001233934A 2000-02-22 2001-02-22 Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis Abandoned AU2001233934A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0004183 2000-02-22
GBGB0004183.0A GB0004183D0 (en) 2000-02-22 2000-02-22 New use
PCT/GB2001/000755 WO2001062796A1 (en) 2000-02-22 2001-02-22 Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis

Publications (1)

Publication Number Publication Date
AU2001233934A1 true AU2001233934A1 (en) 2001-09-03

Family

ID=9886183

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233934A Abandoned AU2001233934A1 (en) 2000-02-22 2001-02-22 Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis

Country Status (5)

Country Link
EP (1) EP1259546A1 (en)
JP (1) JP2003523763A (en)
AU (1) AU2001233934A1 (en)
GB (1) GB0004183D0 (en)
WO (1) WO2001062796A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4140329B2 (en) * 2002-09-25 2008-08-27 財団法人名古屋産業科学研究所 Hypertension risk diagnosis method
US7306913B2 (en) 2002-12-20 2007-12-11 Applera Corporation Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof
US7592156B2 (en) * 2006-07-20 2009-09-22 Wyeth Synthetic dog/human chimeric C-C chemokine receptor 2B

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1002081B1 (en) * 1997-08-14 2006-06-07 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Delayed progression to aids by a missense allele of the ccr2 gene
US6312689B1 (en) * 1998-07-23 2001-11-06 Millennium Pharmaceuticals, Inc. Anti-CCR2 antibodies and methods of use therefor
EP1100963A2 (en) * 1998-07-25 2001-05-23 AstraZeneca AB Human ccr-2 gene polymorphisms

Also Published As

Publication number Publication date
WO2001062796A1 (en) 2001-08-30
GB0004183D0 (en) 2000-04-12
EP1259546A1 (en) 2002-11-27
JP2003523763A (en) 2003-08-12

Similar Documents

Publication Publication Date Title
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001253565A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU2001281369A1 (en) Cardiac disease treatment and device
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2001296550A1 (en) Dermabrasion and skin care apparatus
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2350101A (en) Medical warming device
AU1166502A (en) Human ect2 and methods of use
AU2002952993A0 (en) Therapeutic and diagnostic agents
AU1164601A (en) Therapeutic use and formulation
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
GB0011052D0 (en) Medical device and use thereof
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2001248971A1 (en) Use of npy y1 receptor agonists in the treatment of pain conditions
AU2001233934A1 (en) Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
AU2001274309A1 (en) Phosphoglycan messengers and their medical uses
IL151019A0 (en) Microcompetition and human disease
GB0121774D0 (en) Medical device and use therof
AU2003273112A1 (en) Skin care apparatus having ion-transmission function under the skin and display device thereof
AU2003904303A0 (en) Nerve function and tissue healing
AUPQ223999A0 (en) Intracellular feedback controls in the diagnosis and treatment of human disease
AU2001289700A1 (en) Skin care device
AU2002367140A1 (en) Human sglt homolog promoter and use thereof